FDA Adverse Event Malfunction Summary report: N

GYNECARE MORCELLEX* TISSUE MORCELLATOR

MDR report key: 3030959 · Received April 2, 2013

Report

Report Number
2210968-2013-03302
Event Type
Malfunction
Date Received
April 2, 2013
Date of Event
March 13, 2013
Report Date
March 13, 2013
Manufacturer
ETHICON, INC.
Product Code
HET
PMA / PMN Number
K100280
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
OH, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4): THE ACTUAL DEVICE INVOLVED IN THIS EVENT WAS RETURNED FOR EVALUATION. THE DEVICE WAS VISUALLY AND FUNCTIONALLY EVALUATED. THE BLADE FAILED TO ROTATE DURING THE EVALUATION; IT IS LIKELY THAT THE ACCUMULATION OF BLOOD, BODY FLUIDS, AND TISSUE PREVENTED THE DEVICE FROM CONTINUING TO OPERATE AS INTENDED. IN ADDITION, A REVIEW OF THE BATCH MANUFACTURING RECORDS WAS CONDUCTED AND THE BATCH MET ALL FINISHED GOODS RELEASE CRITERIA.

Additional Manufacturer Narrative · 1

(B)(4). IN ADDITION, A REVIEW OF THE BATCH MANUFACTURING RECORDS WAS CONDUCTED AND THE BATCH MET ALL FINISHED GOODS RELEASE CRITERIA.

Additional Manufacturer Narrative · 1

IT WAS NOTED THAT THE VAGINA WAS EXCEEDINGLY SMALL, VERY DIFFICULT TO EVEN PLACE A SMALL UTERINE MANIPULATOR. THE UTERINE MANIPULATOR IN THE VAGINA WAS VERY TIGHT. THE UTERUS WAS 14CM. THE PROCEDURE PERFORMED WAS A ROBOTIC ASSISTED LAPAROSCOPIC HYSTERECTOMY AND CYSTOSCOPY. THERE WAS NO UNINTENTIONAL DISSECTION.

Additional Manufacturer Narrative · 1

(B)(4). CONCLUSION: THE PRODUCT UPON WHICH THIS MEDWATCH IS BASED IS ANTICIPATED. ONCE THE PRODUCT IS RECEIVED, ANY FURTHER INFORMATION DERIVED FROM THE EVALUATION WILL BE SUBMITTED IN A SUPPLEMENTAL 3500A FORM. THIS IS ONE OF FOUR MEDWATCHES BEING SUBMITTED AS FOUR DEVICES WERE INVOLVED IN THIS EVENT. SEE ALSO MEDWATCH 2210968-2013-03298, MEDWATCH 2210968-2013-03299, AND MEDWATCH 2210968-2013-03301. THE SAME PATIENT IS REPRESENTED IN EACH MEDWATCH.

Description of Event or Problem · 1

IT WAS REPORTED THAT A PATIENT UNDERWENT A ROBOTIC ASSISTED LAPAROSCOPIC HYSTERECTOMY THROUGH A 12 PORT ON (B)(6) 2013. DURING THE PROCEDURE, THE DEVICE STOPPED MORCELLATING ONE MINUTE INTO USE. THE PHYSICIAN TRIED USING A SHAVING TECHNIQUE BUT TO NO AVAIL. THE PHYSICIAN USED LAPAROSCOPIC SCISSORS TO EASILY CUT AROUND THE FIBROIDS IN THE UTERUS AND CONTINUED PERFORMING THE TECHNIQUE TO COMPLETE THE PROCEDURE. THERE WERE NO ADVERSE PATIENT CONSEQUENCES REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
134646 GYNECARE MORCELLEX* TISSUE MORCELLATOR LAPAROSCOPE, GYNECOLOGIC HET ETHICON, INC. NA MT215845

Patients

Seq Age Sex Outcome Treatment
1 43 YR